https://www.selleckchem.com/pr....oducts/crenolanib-cp
To evaluate the impact of the Coronavirus disease of 2019 (COVID-19) pandemic on patients with migraine. Self-reported data from a migraine tracking smartphone application, Migraine Buddy, were used. Data were collected from users who reported at least one attack in the Jan, Feb, Mar and Apr of 2018, 2019 and 2020. In addition, a survey was conducted to evaluate the impact of COVID-19 on migraine management. On average, data from 124,717 users per month (mean age 36.3 ± 10.9years and 89% female) were collected. Overall, the
Like
Comment
Share
